BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 16725292)

  • 21. Radiofrequency ablation of renal tumors with an expandable multitined electrode: results, complications, and pilot evaluation of cooled pyeloperfusion for collecting system protection.
    Rouvière O; Badet L; Murat FJ; Maréchal JM; Colombel M; Martin X; Lyonnet D; Gelet A
    Cardiovasc Intervent Radiol; 2008; 31(3):595-603. PubMed ID: 18247086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up.
    Arzola J; Baughman SM; Hernandez J; Bishoff JT
    Urology; 2006 Nov; 68(5):983-7. PubMed ID: 17095059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report.
    Lee JM; Jin GY; Goldberg SN; Lee YC; Chung GH; Han YM; Lee SY; Kim CS
    Radiology; 2004 Jan; 230(1):125-34. PubMed ID: 14645875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
    Zagoria RJ; Hawkins AD; Clark PE; Hall MC; Matlaga BR; Dyer RB; Chen MY
    AJR Am J Roentgenol; 2004 Jul; 183(1):201-7. PubMed ID: 15208139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors.
    Clasen S; Boss A; Schmidt D; Schraml C; Fritz J; Schick F; Claussen CD; Pereira PL
    J Magn Reson Imaging; 2007 Oct; 26(4):1043-52. PubMed ID: 17896364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.
    Seror O; Haddar D; N'Kontchou G; Ajavon Y; Trinchet JC; Beaugrand M; Sellier N
    J Vasc Interv Radiol; 2005 Jul; 16(7):981-90. PubMed ID: 16002506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of semiflexible applicators for radiofrequency ablation of liver tumors.
    Gaffke G; Gebauer B; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
    Cardiovasc Intervent Radiol; 2006; 29(2):270-5. PubMed ID: 16328685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors.
    Gervais DA; Arellano RS; McGovern FJ; McDougal WS; Mueller PR
    AJR Am J Roentgenol; 2005 Jul; 185(1):72-80. PubMed ID: 15972401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI-guided percutaneous laser ablation of small renal cell carcinoma: Initial clinical experience.
    Kariniemi J; Ojala R; Hellström P; Sequeiros RB
    Acta Radiol; 2010 May; 51(4):467-72. PubMed ID: 20380606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies.
    Brook AL; Gold MM; Miller TS; Gold T; Owen RP; Sanchez LS; Farinhas JM; Shifteh K; Bello JA
    J Vasc Interv Radiol; 2008 May; 19(5):725-35. PubMed ID: 18440462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.
    Matsumoto ED; Johnson DB; Ogan K; Trimmer C; Sagalowsky A; Margulis V; Cadeddu JA
    Urology; 2005 May; 65(5):877-81. PubMed ID: 15882715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
    Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
    Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency ablation of renal tumours: case series of 11 tumours and review of published work.
    Watkins TW; Parkinson R
    Australas Radiol; 2007 Oct; 51(5):412-9. PubMed ID: 17803791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.
    Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
    AJR Am J Roentgenol; 2005 Jul; 185(1):64-71. PubMed ID: 15972400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
    Ahrar K; Matin S; Wood CG; Wallace MJ; Gupta S; Madoff DC; Rao S; Tannir NM; Jonasch E; Pisters LL; Rozner MA; Kennamer DL; Hicks ME
    J Vasc Interv Radiol; 2005 May; 16(5):679-88. PubMed ID: 15872323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
    VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ
    AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.